Navigation Links
Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
Date:9/14/2007

imed at making cancer more treatable. For additional information, please visit http://www.cticseattle.com.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results. Specifically, the risks and uncertainties that could affect the development of XYOTAX include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general and with XYOTAX in particular including, without limitation, the potential failure of XYOTAX to prove safe and effective for treatment of non-small cell lung cancer, determinations by regulatory, patent and administrative governmental authorities, competitive factors, technological developments, costs of developing, producing and selling XYOTAX, and the risk factors listed or described from time to time in the Company's filings with the Securities and Exchange Commission including, without limitation, the Company's most recent filings on Forms 10-K, 8-K, and 10-Q. Except as may be required by Italian law, CTI is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.

Media Contact:

Dan Eramian

T: 206.272.4343

C: 206.854.1200

Susan Callahan

T: 206.272.4472

F: 206.272.4434

E: media@ctiseattle.com

http://www.cticseattle.com/media.htm

Investors Contact:

Leah Grant

T: 206.282.7100

F: 206.272.4434

E: invest@ctiseattle.com

http://www.cticseattle.com/investors.htm


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
3. Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001 at American Association of Cancer Research Annual Meeting
4. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
5. Infertile Voice Supports Stem Cell Research: RESOLVE Calls for Patient Options in Using Frozen Embryos
6. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
7. Independent publication supports the profile of CeNeS phase II compound, CNS 5161
8. Study Supports Cost-Effectiveness of Medtronics Spasticity Treatment for Children with Cerebral Palsy
9. Analyzers Offer Point-of-Care Lipid Panels
10. 2007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion
11. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 6, 2015 NVSSoft, a ... been named a "Cool Vendor" by top IT research firm ... 2015". Gartner defines a "Cool Vendor" as a ... and intriguing. The report highlights that, "as innovation ... in emerging markets should look at local technologies and services, ...
(Date:5/6/2015)... 2015 3D Communications announced ... for helping pharmaceutical companies communicate the value of ... The newly expanded 3D Market Access ... helping companies develop and deliver their "Value Story". It ... engage critical stakeholders earlier in the "innovation-to-market" timeline, ...
(Date:5/6/2015)... --  GenSpera, Inc. (OTCQB: GNSZ) announced today that the ... application process in 17 countries and regions, including ... China , Brazil and ... resulting patent application will extend the exclusivity period for GenSpera,s ... lead drug candidate, mipsagargin, until 2033. This recent ...
Breaking Medicine Technology:UAE-Based Software Developer Named by Gartner as a Cool Vendor 2UAE-Based Software Developer Named by Gartner as a Cool Vendor 3UAE-Based Software Developer Named by Gartner as a Cool Vendor 43D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 23D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 3GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2
... April 5, 2011 / PRNewswire / -- ... today that the U.S. Food and Drug Administration,s (FDA) ... approve Optimer,s investigational antibiotic DIFICID™ (fidaxomicin) for ... infection (CDI), a bacterial infection in the lining of ...
... Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading ... to release its first quarter 2011 financial results on Wednesday, ... financial markets.  The Company will also host a conference call ... 2011 to discuss its financial results and provide an update ...
Cached Medicine Technology:Optimer Announces that the U.S. Food and Drug Administration's Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI) 2Optimer Announces that the U.S. Food and Drug Administration's Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI) 3Optimer Announces that the U.S. Food and Drug Administration's Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI) 4Optimer Announces that the U.S. Food and Drug Administration's Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI) 5Optimer Announces that the U.S. Food and Drug Administration's Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI) 6Watson to Host Conference Call and Webcast to Discuss First Quarter 2011 Earnings 2
(Date:5/6/2015)... TU-Automotive has opened press registration for TU-Automotive ... it to the headlines of major publications world-wide. With ... and Hyundai ready to share their visions for the ... way for press to go behind the scenes and ... TU-Automotive said “This year we’re releasing a preview of ...
(Date:5/6/2015)... The 2015 STEMtech conference exhibition hall ... booth selection . Don’t miss this opportunity to ... and university decision-makers from around the country. , This ... the Arizona Grand in Phoenix. This beautiful all-suite hotel ... doorstep of the South Mountain Preserve. The Phoenix area ...
(Date:5/6/2015)... 2015 Dr. Vito C. Quatela, one of ... recently completed a medical mission trip to Hanoi, Vietnam with ... affected by microtia and other deformities of the face. , ... ended on April 26, Dr. Quatela and his team performed ... congenital deformity where the outside of the ear is underdeveloped. ...
(Date:5/6/2015)... Topical BioMedics, Inc., announces its May Pain Management Webinar will ... streamed live and then archived and accessible on demand 24/7. ... clicking on the following link: http://bit.ly/PMW_FIBRO . ... the webinar, and questions may also be submitted in advance ... the May webinar is “What You need to Know about ...
(Date:5/6/2015)... The Florida Council on Compulsive Gambling, Inc. (FCCG), along ... Geriatric Education Center, Mental Health Association of Southeast Florida, ... Abuse, will hold its annual conference in Ft Lauderdale ... , This important event will address topics such as ... clinical training for problem gambling treatment services. “This ...
Breaking Medicine News(10 mins):Health News:Press Registration for TU-Automotive Detroit Now Open 2Health News:STEMtech Conference Exhibitors Gain Access to Community College and University Representatives From Across the U.S. 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 3Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 2Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 3Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 4Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 5Health News:Conference on Problem Gambling to be held in Ft. Lauderdale, FL 2
... a night,s rest may be the cause, research finds , ... the body,s production of the hormone melatonin, potentially leading to ... people often have problems with sleep after a brain injury, ... these problems," study author Shantha Rajaratnam of Monash University in ...
... is available by prescription under trade name Xenical and ... -- Responding to reports of rare but sometimes severe ... announced revised labels for a widely used weight-loss drug. ... the trade name Xenical and over-the-counter as Alli. , ...
... idea of individualized therapies, experts say , WEDNESDAY, May 26 ... not two, but potentially tens of thousands of genetic mutations ... A sample from a lung tumor from a heavy smoker ... 27 issue of Nature . , "People in the ...
... of individualized therapies, experts say , WEDNESDAY, May 26 (HealthDay ... two, but potentially tens of thousands of genetic mutations which, ... sample from a lung tumor from a heavy smoker revealed ... issue of Nature . , "People in the field ...
... development of a fast, simple, inexpensive method for determining ... skin allergies in people -- a method that does ... ACS, Chemical Research in Toxicology , a monthly ... the existence of public sentiment against the use of ...
... 26, 2010) Joan W. Miller, M.D., the HMS Henry ... of ophthalmology at Massachusetts Eye and Ear Infirmary and the ... Martin Dean,s Leadership Award for the Advancement of Women Faculty. ... was initiated by Joseph Martin, former HMS dean, in 1998. ...
Cached Medicine News:Health News:Brain Injuries May Lead to Sleep Woes 2Health News:Rare Cases of Liver Damage Tied to Weight-Loss Drug 2Health News:Rare Cases of Liver Damage Tied to Weight-Loss Drug 3Health News:Single Lung Tumor Contains 50,000 Mutations 2Health News:Single Lung Tumor Contains 50,000 Mutated Genes 2Health News:Joan Miller, M.D., receives 2010 Leadership Award for the Advancement of Women Faculty 2
This Flex Goggle has a unique wrap around design which fits the contour of the face and brow for optimum coverage. The ratchet style temple hinge allows multiple adjustments in, out, up and down for...
... optical steel base metal with gold electro-plate, ... durability. Includes adjustable non-slip silicon nose pads ... with custom fitted lead sheet side shields ... lenses for increased scatter radiation protection. (Temples ...
... of optical steel base ... Comes with custom fitted ... create a seal to ... increased scatter radiation protection. ...
... Stylish and comfortable eye protection ... approximately 90% of scatter radiation. Our high ... protection and comfort with minimized weight. Our ... leaded) optics that meet all industry standards. ...
Medicine Products: